Advances in Cancer Immunotherapy™ - Los Angeles, CA

When:  Jun 29, 2017 from 2:00 PM to 8:00 PM (PT)

Organizers: sitc_log_color.png
Teresa Kim, RN, BSN – City of Hope
Kim A. Margolin, MD – City of Hope
Daphne Stewart, MD – City of Hope

Share This Event In Your Network

ACI Program Registration Information

Program Purpose

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these six-hour programs will facilitate understanding of:

  • The rationale for common approaches to immunotherapy
  • The clinical applications of immunotherapy for disease states with FDA-approved treatments (melanoma, and lung, genitourinary, hematologic and head and neck cancers)
  • Operational and reimbursement barriers to implementing immunotherapy in a community setting and strategies to overcome them
  • The identification and management of immune-related adverse events from the nursing and prescriber perspective in the clinic and emergency settings

Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through two Immuno-Oncology (IO) Cup o' Joe webinars after the program, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice. Breakfast and lunch will be served at the live portion of this event.

For more information, including program objectives, click here.

This program is presented in collaboration with the American Academy of Emergency Medicine (AAEM) and the Association of Community Cancer Centers (ACCC).      




Program Registration

Advance online registration for the Advances in Cancer Immunotherapy™ in Los Angeles, CA is NOW CLOSED.

On-site registration will be available as space permits. You can find a PDF version of the registration form here.

SITC members are eligible for discounted registration rates. To receive discounted member rates, your membership dues must be current through 2017.

Click here to learn more about the registration rates for members and non-members for this program.

Program Agenda

Preprogram Course: Introduction to Immunology

Participation in this online preprogram course is strongly recommended as it contains information that will not be covered at the program on June 29. This interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program. Please click HERE to access the course.

June 29 Program

5.5 AMA PRA Category 1 Credits™ Click here for more detailed CME, CNE and CPE information and program objectives.

Presentations include time for Audience Response System (ARS)-assisted audience
interaction as well as general question and answer time.

1 – 2 p.m.

Check-in, Onsite Registration and Networking

Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice

Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy

2 – 2:05 p.m.

Welcome, Introduction, and Pretest Questions by the Society for Immunotherapy of Cancer

2:05 – 2:35 p.m.

Basic Principles of Cancer Immunotherapy
Elizabeth Budde, MD, PhD – City of Hope

2:35 – 2:55 p.m.

Immunotherapy for the Treatment of Lung Cancer
Jonathan W. Goldman, MD – University of California, Los Angeles

2:55 – 3:15 p.m.

Immunotherapy for the Treatment of Melanoma
Kim A. Margolin, MD – City of Hope

3:15 – 3:35 p.m.

Immunotherapy for the Treatment of Genitourinary Cancers
Sumanta Kumar Pal, MD – City of Hope

3:35 – 3:55 p.m

Immunotherapy for the Treatment of Hematologic Malignancies
Alex Herrera, MD – City of Hope

3:55 – 4:05 p.m


Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice

4:05 – 4:10 p.m.

Information About the Society for Immunotherapy of Cancer Resources

4:10 – 4:40 p.m.

Effective Practices for Incorporating Immunotherapy Into Hospital Operations
Timothy Tyler, PharmD, FHOPA, FCSHP – Comprehensive Cancer Center, Desert Regional Medical Center

4:40 – 5:10 p.m.

Coverage and Reimbursement Challenges and Strategies
Linda Bosserman, MD, FASCO, FACP – City of Hope

5:10 – 5:30 p.m

Immunotherapy for the Treatment of Head and Neck Cancers
Erminia Massarelli, MD, PhD, MS – City of Hope

5:30 – 5:35 p.m.

Take-Home Points for Part A

5:35 – 6 p.m.


Part B: Immune-Related Adverse Event (irAE) Management

6 – 6:20 p.m.

Mechanisms of Immune-Related Adverse Events
Kim A. Margolin, MD – City of Hope

6:20 – 6:50 p.m.

Nursing Perspective on irAEs: Patient Education, Monitoring and Management
Neena Kennedy, RN, BSN – City of Hope
Teresa Kim, RN, BSN City of Hope

6:50 – 7:20 p.m.

Management and Mitigation of irAEs for Immunotherapy Prescribers
Gino K. In, MD, MPH – Keck School of Medicine, University of Southern California

7:20 – 7:25 p.m.

Referring Patients to Specialists for irAEs: Dermatologic Toxicities
Badri Modi, MD – City of Hope

7:25 – 7:55 p.m.

Identification and Management of Immune-Related Adverse Events in the Emergency Setting
William Goldenberg, MD, FAAEM  Naval Medical Center, San Diego

7:55 – 8 p.m.

Posttest Questions by the Society for Immunotherapy of Cancer

8 – 8:05 p.m.

Take-Home Points for Part B and Closing Remarks

The 2017 Advances in Cancer Immunotherapy™ series is supported in part by independent medical educational grants
from Aduro Biotech, Inc., Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Merck & Co., Inc. and Prometheus Laboratories Inc.

#Biomarkers #PatientAdvocate #InPersonEvent #Cytokines #Pharmacist #LungCancers #AdvancesinCancerImmunotherapy(ACI) #HeadandNeckCancers #2017 #Adverse Events #SkinCancers #Toxicities #GenitourinaryCancers #HematologicMalignancies #Cancer Immunotherapy Guidelines #Patient #AlliedHealth #Nurse #Oncologist #ImmuneCheckpointInhibitors #Clinician #ProstateCancer


Hilton Pasadena
168 S Los Robles Ave.
Pasadena, CA 91101